Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Mounjaro: Targets both GLP-1 and GIP receptors, offering a dual-action mechanism that has shown greater effectiveness in controlling blood sugar and supporting weight loss
GHK-Cu dosage can be personalized by age, but there is no official age-based dosing chart like you would see with prescription medication
First, you get matched with a licensed provider who specializes in weight management
The results showed that patients with a mean baseline body weight of 106.9 kg who were treated with CagriSema (2.4/2.4 mg) achieved 22.7% weight loss after 68 weeks, compared to 11.8% of those treated with cagrilintide 2.4 mg monotherapy and 16.1% of those treated with semaglutide 2.4 mg monotherapy, and to 2.3% of those receiving only the placebo [125]
